ScholarIQanswers from OpenAlex
Universitat Autònoma de Barcelona
InstitutionResearch output, impact & collaborations
Universitat Autònoma de Barcelona is a institution indexed in ScholarIQ from OpenAlex.
What is known about Universitat Autònoma de Barcelona?
ScholarIQrecord summary
Universitat Autònoma de Barcelona is a research organisation in Cerdanyola del Vallès, ES. OpenAlex records 164,803 works and 12,755,431 citations for it. 26,587 researchers list it as their most recent affiliation.
How many works does Universitat Autònoma de Barcelona have?
ScholarIQindexed works
Universitat Autònoma de Barcelona has 164,803 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Universitat Autònoma de Barcelona have?
ScholarIQcitation count
Universitat Autònoma de Barcelona has 12,755,431 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Universitat Autònoma de Barcelona?
ScholarIQresearcher count
Universitat Autònoma de Barcelona has 26,587 researchers in the ScholarIQ index.
What is the average h-index at Universitat Autònoma de Barcelona?
ScholarIQavg h-index
Universitat Autònoma de Barcelona has an average h-index of 66.7 in OpenAlex.
What is the ROR of Universitat Autònoma de Barcelona?
ScholarIQror
The ROR for Universitat Autònoma de Barcelona is on the source record.
What is the OpenAlex record for Universitat Autònoma de Barcelona?
ScholarIQopenalex
The OpenAlex for Universitat Autònoma de Barcelona is on the source record.
What is the Wikidata of Universitat Autònoma de Barcelona?
ScholarIQwikidata
The Wikidata for Universitat Autònoma de Barcelona is on the source record.
Who are the most-cited researchers behind Universitat Autònoma de Barcelona?
ScholarIQtop researchers by citations
What are the most-cited papers on Universitat Autònoma de Barcelona?
ScholarIQmost cited works
Observation of a new particle in the search for the Standard Model Higgs boson with the ATLAS detector at the LHC
G. Aad, T. Abajyan, B. Abbott, J. Abdallah, S. Abdel Khalek, A. A. Abdelalim, O. Abdinov, R. Aben, B. Abi, M. Abolins, O. S. AbouZeid, H. Abramowicz, H. Abreu, B. S. Acharya, L. Adamczyk, D. L. Adams, T. N. Addy, J. Adelman, S. Adomeit, P. Adragna, T. Adye, S. Aefsky, J. A. Aguilar–Saavedra, M. Agustoni, M. Aharrouche, S. P. Ahlen, F. Ahles, A. Ahmad, M. Ahsan, G. Aielli, T. Akdoğan, T. P. A. Åkesson, G. Akimoto, A. V. Akimov, M. S. Alam, M. A. Alam, J. Albert, S. Albrand, M. Aleksa, I. N. Aleksandrov, F. Alessandria, C. Alexa, G. Alexander, G. Alexandre, T. Alexopoulos, M. Alhroob, M. Aliev, G. Alimonti, J. Alison, B. M. M. Allbrooke, P. P. Allport, S. E. Allwood-Spiers, J. Almond, A. Aloisio, R. Alon, A. Alonso, F. Alonso, A. Altheimer, B. Álvarez González, M. G. Alviggi, K. Amako, C. Amelung, V. V. Ammosov, D. Roda Dos Santos, A. Amorim, N. Amram, C. Anastopoulos, L. S. Ancu, N. Andari, T. Andeen, C. F. Anders, G. Anders, K. J. Anderson, A. Andreazza, V. Andrei, M.-L. Andrieux, X. S. Anduaga, S. Angelidakis, P. Anger, A. Angerami, F. Anghinolfi, A. V. Anisenkov, N. Anjos, A. Annovi, A. Antonaki, M. Antonelli, А. Антонов, J. Antoš, F. Anulli, M. Aoki, S. Aoun, L. Aperio Bella, R. Apolle, G. Arabidze, I. Aracena, Y. Arai, A. T. H. Arce, S. Arfaoui, J-F. Arguin, E. Arık
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results
Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn, Pablo Martínez‐Martín, Werner Poewe, Cristina Sampaio, Matthew B. Stern, Richard Dodel, Bruno Dubois, Robert G. Holloway, Joseph Jankovic, Jaime Kulisevsky, Anthony E. Lang, Andrew J. Lees, Sue E. Leurgans, Peter A. LeWitt, David L. Nyenhuis, C. Warren Olanow, Olivier Rascol, Anette Schrag, Jeanne A. Teresi, Jacobus J. van Hilten, Nancy R. LaPelle
Association of single nucleotide polymorphisms in the lens epithelium-derived growth factor (LEDGF/p75) with HIV-1 infection outcomes in brazilian HIV-1+ individuals
Núria Mallorquí‐Bagué, Ana B. Fagundo, Susana Jiménez Murcia, Rafael de la Torre Fornell, Rosa M. Baños, Cristina Botella, Felipe F. Casanueva, Ana B. Crujeiras, José C. Fernández García, Jose M. Fernández Real, Gema Frühbeck, Roser Granero, Amaia Rodrı́guez, Iris Tolosa‐Sola, Francesc Ortega, Francisco José Tinahones Madueño, Eva Alvarez-Moya, Cristian Ochoa, José M. Menchón, Fernando Fernández Aranda
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes, Laura Evans, Waleed Alhazzani, Mitchell M. Levy, Massimo Antonelli, Ricard Ferrer, Anand Kumar, Jonathan Sevransky, Charles L. Sprung, Mark Nunnally, Bram Rochwerg, Gordon D. Rubenfeld, Derek C. Angus, Djillali Annane, Richard Beale, Geoffrey J. Bellinghan, Gordon R. Bernard, Jean‐Daniel Chiche, Craig Coopersmith, Daniel De Backer, Craig French, Seitaro Fujishima, Herwig Gerlach, Jorge Hidalgo, Steven M. Hollenberg, Alan E. Jones, Dilip R. Karnad, Ruth Kleinpell, Koh Y, Thiago Lisboa, Flávia Ribeiro Machado, John J. Marini, John C. Marshall, John E. Mazuski, Lauralyn McIntyre, Anthony S. McLean, Sangeeta Mehta, Rui P. Moreno, John Myburgh, Paolo Navalesi, Osamu Nishida, Tiffany M. Osborn, Anders Perner, Colleen M. Plunkett, Marco Ranieri, Christa Schorr, Maureen A. Seckel, Christopher W. Seymour, Lisa Shieh, Khalid Shukri, Steven Q. Simpson, Mervyn Singer, Bruce Thompson, Sean R. Townsend, T. van der Poll, Jean‐Louis Vincent, W. Joost Wiersinga, Janice L. Zimmerman, R. Phillip Dellinger
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder, Amita Patnaik, Charu Aggarwal, Matthew A. Gubens, Leora Horn, Enric Carcereny, Myung‐Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D. Hellmann, Omid Hamid, Jonathan W. Goldman, Jean‐Charles Soria, Marisa Dolled‐Filhart, Ruth Z. Rutledge, Jin Zhang, Jared Lunceford, Reshma Rangwala, Gregory M. Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi
How much of the research on Universitat Autònoma de Barcelona is open access?
ScholarIQopen access share
100%OPEN ACCESS